Covered recipient · General Payments record
HALEY LAYMANCE
Physician Assistants & Advanced Practice Nursing Providers Nurse Practitioner Family
General Payments · PY2022–2024
$987.76
- Reported across 35 records
- CMS publication 2026-01-23
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2024 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $431.31 | 15 |
By paying entity
PY2024 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| Kerecis Limited | $134.16 | 3 |
| Acera Surgical, Inc. | $74.53 | 3 |
| Octapharma USA, Inc. | $50.25 | 2 |
| Ethicon US, LLC | $42.70 | 2 |
| ConvaTec Inc. | $39.30 | 1 |
| ABBVIE INC. | $33.88 | 1 |
| La Jolla Pharmaceutical Company | $20.82 | 1 |
| Abbott Laboratories | $20.37 | 1 |
| Integra LifeSciences Corporation | $15.30 | 1 |
By program year
All program years on this page · sorted by year
Payment records · PY2024 (15)
Sorted by paying entity, then date · as published by CMS
| Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Record ID | Source |
|---|---|---|---|---|---|---|---|
| Abbott Laboratories | $20.37 | 12/02/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1124792412 | CMS |
| ABBVIE INC. | $33.88 | 03/27/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1107516691 | CMS |
| Acera Surgical, Inc. | $24.84 | 11/01/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1152409640 | CMS |
| Acera Surgical, Inc. | $23.78 | 11/12/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1152409638 | CMS |
| Acera Surgical, Inc. | $25.91 | 12/04/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1152409642 | CMS |
| ConvaTec Inc. | $39.30 | 02/14/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1151391241 | CMS |
| Ethicon US, LLC | $17.87 | 02/01/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1077645476 | CMS |
| Ethicon US, LLC | $24.83 | 07/01/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1077645472 | CMS |
| Integra LifeSciences Corporation | $15.30 | 07/09/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1140145490 | CMS |
| Kerecis Limited | $43.87 | 02/06/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1120094173 | CMS |
| Kerecis Limited | $34.07 | 06/21/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1120112532 | CMS |
| Kerecis Limited | $56.22 | 08/19/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1120105652 | CMS |
| La Jolla Pharmaceutical Company | $20.82 | 05/21/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1154253180 | CMS |
| Octapharma USA, Inc. | $18.02 | 04/24/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1142322596 | CMS |
| Octapharma USA, Inc. | $32.23 | 05/15/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1142322598 | CMS |
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-01-23
- Program years on this page
- 2022, 2023, 2024
- Source files
- Dataset page · Bulk file · PY2022 , PY2023 , PY2024
- Generated from
- OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.